Novo Nordisk Investigational Site

Asahikawa-shi, Hokkaido 078-8510

0 studies enrolling now · 2 studies all time

What they study most

Diabetes, Diabetes Mellitus, Type 2, Hepatobiliary Disorders, Non-alcoholic Steatohepatitis

Studies at this site

• Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes — Completed
• Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis. — Completed